Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
123599
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
510415
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
46590
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
46590
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
CINRYZE (AUTHORIZED: ANGIOEDEMAS, HEREDITARY)
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
67592
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
602117
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
WHO-ATC |
B06AC01
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
510415
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
95296
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
NCI_THESAURUS |
C471
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
46490
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
NDF-RT |
N0000184172
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
NDF-RT |
N0000184172
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
185804
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
46490
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
95296
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/09/668
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
809864
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
PRIMARY | RxNorm | ||
|
N0000010252
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
PRIMARY | Decreased Vascular Permeability [PE] | ||
|
SUB130159
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
PRIMARY | |||
|
C87730
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
PRIMARY | |||
|
SUB39564
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
PRIMARY | |||
|
100000129592
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
PRIMARY | |||
|
DB06404
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
PRIMARY | |||
|
SUB39564
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
PRIMARY | |||
|
6KIC4BB60G
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
PRIMARY | |||
|
1018837-94-9
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
PRIMARY | |||
|
6KIC4BB60G
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
PRIMARY | |||
|
N0000184151
Created by
admin on Fri Dec 15 16:30:43 GMT 2023 , Edited by admin on Fri Dec 15 16:30:43 GMT 2023
|
PRIMARY | Kallikrein Inhibitors [MoA] |
ACTIVE MOIETY